Contraception is still necessary after menopause. Women who are over 50 years old should use contraception for at least 12 months after their last period, while those under 50 years old should use it for at least 24 months after their last period.

Understanding Menopause and Contraception

Menopause is a natural biological process that marks the end of a woman’s reproductive years. On average, women in the UK experience menopause at the age of 51. However, prior to menopause, women may experience a period known as the climacteric. During this time, ovarian function starts to decline, and women may experience symptoms such as hot flashes, mood swings, and vaginal dryness.

It is important for women to understand that they can still become pregnant during the climacteric period. Therefore, it is recommended to use effective contraception until a certain period of time has passed. Women over the age of 50 should use contraception for 12 months after their last period, while women under the age of 50 should use contraception for 24 months after their last period. By understanding menopause and the importance of contraception during the climacteric period, women can make informed decisions about their reproductive health.

Trichomonas vaginalis is linked to a strawberry cervix, which can have symptoms resembling those of bacterial vaginosis.

Bacterial vaginosis (BV) is a condition where there is an overgrowth of anaerobic organisms, particularly Gardnerella vaginalis, in the vagina. This leads to a decrease in the amount of lactobacilli, which produce lactic acid, resulting in an increase in vaginal pH. BV is not a sexually transmitted infection, but it is commonly seen in sexually active women. Symptoms include a fishy-smelling vaginal discharge, although some women may not experience any symptoms at all. Diagnosis is made using Amsel’s criteria, which includes the presence of thin, white discharge, clue cells on microscopy, a vaginal pH greater than 4.5, and a positive whiff test. Treatment involves oral metronidazole for 5-7 days, with a cure rate of 70-80%. However, relapse rates are high, with over 50% of women experiencing a recurrence within 3 months. Topical metronidazole or clindamycin may be used as alternatives.

Bacterial vaginosis during pregnancy can increase the risk of preterm labor, low birth weight, chorioamnionitis, and late miscarriage. It was previously recommended to avoid oral metronidazole in the first trimester and use topical clindamycin instead. However, recent guidelines suggest that oral metronidazole can be used throughout pregnancy. The British National Formulary (BNF) still advises against using high-dose metronidazole regimes. Clue cells, which are vaginal epithelial cells covered with bacteria, can be seen on microscopy in women with BV.

Antipsychotics are a group of drugs used to treat schizophrenia, psychosis, mania, and agitation. They are divided into two categories: typical and atypical antipsychotics. The latter were developed to address the extrapyramidal side-effects associated with the first generation of typical antipsychotics. Typical antipsychotics work by blocking dopaminergic transmission in the mesolimbic pathways through dopamine D2 receptor antagonism. They are associated with extrapyramidal side-effects and hyperprolactinaemia, which are less common with atypical antipsychotics.

Extrapyramidal side-effects (EPSEs) are common with typical antipsychotics and include Parkinsonism, acute dystonia, sustained muscle contraction, akathisia, and tardive dyskinesia. The latter is a late onset of choreoathetoid movements that may be irreversible and occur in 40% of patients. The Medicines and Healthcare products Regulatory Agency has issued specific warnings when antipsychotics are used in elderly patients, including an increased risk of stroke and venous thromboembolism. Other side-effects include antimuscarinic effects, sedation, weight gain, raised prolactin, impaired glucose tolerance, neuroleptic malignant syndrome, reduced seizure threshold, and prolonged QT interval.

It is common for children under the age of 3 to have bow legs, which is considered a normal variation. Typically, this condition resolves on its own by the time the child reaches 4 years old.

Common Lower Limb Variants in Children

Parents often become concerned when they notice apparent abnormalities in their child’s lower limbs. This can lead to a visit to their primary care physician and a referral to secondary care. However, many of these presentations are actually normal variants that will resolve on their own.

One common variant is flat feet, where the child’s medial arch is absent when standing. This typically resolves between the ages of 4-8 years and does not require orthotics. In-toeing is another common presentation, which can be caused by metatarsus adductus, internal tibial torsion, or femoral anteversion. Most cases resolve spontaneously, but severe or persistent cases may require intervention. Out-toeing is also common in early infancy and usually resolves by the age of 2 years.

Bow legs, or genu varum, is another normal variant that presents in the first or second year of life. This is characterized by an increased intercondylar distance and typically resolves by the age of 4-5 years. Knock knees, or genu valgum, presents in the third or fourth year of life and is characterized by an increased intermalleolar distance. This also typically resolves spontaneously.

Overall, it is important for parents to be aware of these common lower limb variants in children and to seek medical advice if they have concerns. However, in many cases, parental reassurance and monitoring is all that is needed.

Despite the absence of symptoms, the patient’s blood pressure remains elevated at a level exceeding 160/100 mmHg, and there is also significant proteinuria, despite receiving labetalol treatment. As a result, emergency admission is necessary to monitor and manage the hypertension in a controlled setting. If there is no improvement, delivery may be considered as an option.

Hypertension during pregnancy is a common occurrence that requires careful management. In normal pregnancies, blood pressure tends to decrease in the first trimester and then gradually increase to pre-pregnancy levels by term. However, in cases of hypertension during pregnancy, the systolic blood pressure is usually above 140 mmHg or the diastolic blood pressure is above 90 mmHg. Additionally, an increase of more than 30 mmHg systolic or 15 mmHg diastolic from the initial readings may also indicate hypertension.

There are three categories of hypertension during pregnancy: pre-existing hypertension, pregnancy-induced hypertension (PIH), and pre-eclampsia. Pre-existing hypertension refers to a history of hypertension before pregnancy or elevated blood pressure before 20 weeks gestation. PIH occurs in the second half of pregnancy and resolves after birth. Pre-eclampsia is characterized by hypertension and proteinuria, and may also involve edema.

The management of hypertension during pregnancy involves the use of antihypertensive medications such as labetalol, nifedipine, and hydralazine. In cases of pre-existing hypertension, ACE inhibitors and angiotensin II receptor blockers should be stopped immediately and alternative medications should be prescribed. Women who are at high risk of developing pre-eclampsia should take aspirin from 12 weeks until the birth of the baby. It is important to carefully monitor blood pressure and proteinuria levels during pregnancy to ensure the health of both the mother and the baby.

Clomifene is the recommended first-line treatment for infertility in patients with PCOS. This patient has been diagnosed with PCOS, which can cause infertility and other symptoms such as hirsutism. Clomifene works by inducing ovulation and has been shown to improve fertility outcomes in these patients.

Goserelin is not a suitable treatment for infertility in PCOS patients. It is a gonadotrophin-releasing hormone agonist used for conditions such as prostate carcinoma, endometriosis, and dysfunctional uterine bleeding. In-vitro fertilisation is not typically the first option for improving fertility in PCOS patients and is usually considered later on.

While metformin is an important drug in the management of PCOS, it is not the primary treatment for improving fertility. It is often prescribed in combination with clomifene to address metabolic issues associated with PCOS. However, clomifene is the key drug for improving overall fertility outcomes in these patients.

Managing Polycystic Ovarian Syndrome

Polycystic ovarian syndrome (PCOS) is a condition that affects a significant percentage of women of reproductive age. The exact cause of PCOS is not fully understood, but it is associated with high levels of luteinizing hormone and hyperinsulinemia. Management of PCOS is complex and varies depending on the individual’s symptoms. Weight reduction is often recommended, and a combined oral contraceptive pill may be used to regulate menstrual cycles and manage hirsutism and acne. If these symptoms do not respond to the pill, topical eflornithine or medications like spironolactone, flutamide, and finasteride may be used under specialist supervision.

Infertility is another common issue associated with PCOS. Weight reduction is recommended, and the management of infertility should be supervised by a specialist. There is ongoing debate about the most effective treatment for infertility in patients with PCOS. Clomifene is often used, but there is a potential risk of multiple pregnancies with anti-oestrogen therapies like clomifene. Metformin is also used, either alone or in combination with clomifene, particularly in patients who are obese. Gonadotrophins may also be used to stimulate ovulation. The Royal College of Obstetricians and Gynaecologists (RCOG) published an opinion paper in 2008 and concluded that on current evidence, metformin is not a first-line treatment of choice in the management of PCOS.

When there is suspicion of a spinal epidural abscess, a complete MRI of the spine is necessary to detect any skip lesions.

To accurately diagnose a spinal epidural abscess, a full spine MRI is essential. Neither plain x-rays nor CT scans can effectively identify the abscess. It is necessary to scan the entire spine, not just the suspected area, as there may be multiple separate abscesses that are not connected. The MRI should be requested and performed as soon as possible.

Understanding Spinal Epidural Abscess

A spinal epidural abscess (SEA) is a serious condition that occurs when pus collects in the spinal epidural space, which is the area surrounding the spinal cord. This condition requires immediate medical attention to prevent further damage to the spinal cord. SEA can be caused by bacteria that enters the spinal epidural space through contiguous spread from adjacent structures, haematogenous spread from concomitant infection, or direct infection. Patients with immunosuppression are at a higher risk of developing SEA. The most common causative micro-organism is Staphylococcus aureus. Symptoms of SEA include fever, back pain, and focal neurological deficits according to the segment of the cord affected.

To diagnose SEA, doctors may perform blood tests, blood cultures, and an infection screen. An MRI of the whole spine is necessary to identify the extent of the abscess. If the primary source of infection is not clear, further investigations may be required, such as echocardiography and dental x-rays. Treatment for SEA involves a long-term course of antibiotics, which may be refined based on culture results. Patients with large or compressive abscesses, significant or progressive neurological deficits, or those who are not responding to antibiotics alone may require surgical evacuation of the abscess.

Bell’s palsy affects the lower motor neurons and results in weakness of the entire side of the face. A left cranial nerve VII lower motor neuron lesion would cause left-sided facial weakness without forehead sparing. However, lateral medullary syndrome, caused by ischemia to the lateral medulla oblongata, would present with vertigo, dizziness, nystagmus, ataxia, nausea and vomiting, and dysphagia. A left cranial nerve VII upper motor neuron lesion would result in right-sided facial weakness with forehead sparing, while a right cranial nerve VII lower motor neuron lesion would cause right-sided facial weakness without forehead sparing.

Understanding Bell’s Palsy

Bell’s palsy is a sudden, one-sided facial nerve paralysis of unknown cause. It is more common in individuals aged 20-40 years and pregnant women. The condition is characterized by lower motor neuron facial nerve palsy, which affects the forehead. Unlike upper motor neuron lesions, the upper face is spared. Patients may also experience post-auricular pain, altered taste, dry eyes, and hyperacusis.

The management of Bell’s palsy has been a subject of debate. However, it is now widely accepted that all patients should receive oral prednisolone within 72 hours of onset. The addition of antiviral medications is still a matter of discussion, but it may be beneficial for severe facial palsy. Eye care is also crucial to prevent exposure keratopathy, and patients should be prescribed artificial tears and eye lubricants. If they are unable to close their eyes at bedtime, they should tape them closed using microporous tape.

If the paralysis shows no sign of improvement after three weeks, an urgent referral to ENT is necessary. Patients with long-standing weakness may require a referral to plastic surgery. The prognosis for Bell’s palsy is generally good, with most patients making a full recovery within 3-4 months. However, untreated patients may experience permanent moderate to severe weakness in around 15% of cases.

To determine a patient’s immune status for Hepatitis B, a systematic approach is necessary. First, antigenic results are examined to determine if the virus is present, followed by antibody results to assess the body’s response to the virus. In this case, negative results for both HBsAg and HBcAg indicate no active infection, while the presence of antibodies to both antigens suggests a previous infection that has been cleared, resulting in immunity.

In acute infection, both HBsAg and HBcAg are positive, with a limited antibody response. Chronic infection is characterized by ongoing viral infection and an inadequate immune response, resulting in the virus not being cleared. Immunization exposes the immune system to purified viral protein, resulting in the production of anti-HBs antibodies and conferring some immunity.

To distinguish between immunization and previous infection, the absence of anti-HBc antibodies indicates immunization, as there are no viral antigens present. If an individual has never been exposed to any Hepatitis B antigens, all serology tests would be negative.

Interpreting hepatitis B serology is an important skill that is still tested in medical exams. It is crucial to keep in mind a few key points. The surface antigen (HBsAg) is the first marker to appear and triggers the production of anti-HBs. If HBsAg is present for more than six months, it indicates chronic disease, while its presence for one to six months implies acute disease. Anti-HBs indicates immunity, either through exposure or immunization, and is negative in chronic disease. Anti-HBc indicates previous or current infection, with IgM anti-HBc appearing during acute or recent hepatitis B infection and persisting IgG anti-HBc. HbeAg is a marker of infectivity and HBV replication.

To illustrate, if someone has been previously immunized, their anti-HBs will be positive, while all other markers will be negative. If they had hepatitis B more than six months ago but are not a carrier, their anti-HBc will be positive, and HBsAg will be negative. However, if they are now a carrier, both anti-HBc and HBsAg will be positive. If HBsAg is present, it indicates an ongoing infection, either acute or chronic if present for more than six months. On the other hand, anti-HBc indicates that the person has caught the virus, and it will be negative if they have been immunized.

According to NICE guidelines for suspected lung cancers, individuals over the age of 40 with finger clubbing should undergo a chest X-ray. Given that this patient is 70 years old and has a persistent cough and finger clubbing, an urgent chest X-ray is necessary to investigate the possibility of lung cancer or mesothelioma. Pain relief medication such as oral analgesia or ibuprofen gel is not necessary as the patient is not experiencing any pain, which would be indicative of osteoarthritis. Reassurance is not appropriate in this case as finger clubbing in individuals over the age of 40 requires immediate investigation.

Referral Guidelines for Lung Cancer

Lung cancer is a serious condition that requires prompt diagnosis and treatment. The 2015 NICE cancer referral guidelines provide clear advice on when to refer patients for further assessment. According to these guidelines, patients should be referred using a suspected cancer pathway referral if they have chest x-ray findings that suggest lung cancer or if they are aged 40 and over with unexplained haemoptysis.

For patients aged 40 and over who have two or more unexplained symptoms, or who have ever smoked and have one or more unexplained symptoms, an urgent chest x-ray should be offered within two weeks to assess for lung cancer. These symptoms include cough, fatigue, shortness of breath, chest pain, weight loss, and appetite loss.

In addition, an urgent chest x-ray should be considered within two weeks for patients aged 40 and over who have persistent or recurrent chest infection, finger clubbing, supraclavicular lymphadenopathy or persistent cervical lymphadenopathy, chest signs consistent with lung cancer, or thrombocytosis.

Overall, these guidelines provide clear and specific criteria for when to refer patients for further assessment for lung cancer. By following these guidelines, healthcare professionals can ensure that patients receive timely and appropriate care.

The appropriate surgical procedure for a patient with rectal cancer on the anal verge is abdominoperineal excision of the rectum. This procedure involves the removal of the anus, rectum, and a section of the sigmoid colon. Symptoms of rectal cancer include blood mixed with stools, changes in bowel habits, and copious mucus in stools. Haemorrhoidectomy is not the correct choice for this patient as the diagnosis is unlike. High anterior resection is used for upper rectal tumours, while low anterior resection is used for low rectal tumours, but not for anal verge tumours. Rubber band ligation is used to treat haemorrhoids in outpatient clinics, which is not the diagnosis for this patient.

Colorectal cancer is typically diagnosed through CT scans and colonoscopies or CT colonography. Patients with tumors below the peritoneal reflection should also undergo MRI to evaluate their mesorectum. Once staging is complete, a treatment plan is formulated by a dedicated colorectal MDT meeting.

For colon cancer, surgery is the primary treatment option, with resectional surgery being the only cure. The procedure is tailored to the patient and tumor location, with lymphatic chains being resected based on arterial supply. Anastomosis is the preferred method of restoring continuity, but in some cases, an end stoma may be necessary. Chemotherapy is often offered to patients with risk factors for disease recurrence.

Rectal cancer management differs from colon cancer due to the rectum’s anatomical location. Tumors can be surgically resected with either an anterior resection or an abdomino-perineal excision of rectum (APER). A meticulous dissection of the mesorectal fat and lymph nodes is integral to the procedure. Neoadjuvant radiotherapy is often offered to patients prior to resectional surgery, and those with obstructing rectal cancer should have a defunctioning loop colostomy.

Segmental resections based on blood supply and lymphatic drainage are the primary operations for cancer. The type of resection and anastomosis depend on the site of cancer. In emergency situations where the bowel has perforated, an end colostomy is often safer. Left-sided resections are more risky, but ileo-colic anastomoses are relatively safe even in the emergency setting and do not need to be defunctioned.

While acanthosis nigricans may occur on its own in individuals with dark skin, it is typically a sign of insulin resistance and associated conditions such as type 2 diabetes, polycystic ovarian syndrome, Cushing’s syndrome, and hypothyroidism. Certain medications, including corticosteroids, insulin, and hormone medications, can also cause this condition. If acanthosis nigricans appears suddenly and in unusual areas such as the mouth, it may indicate the presence of an internal malignancy, particularly gastric cancer.

Acanthosis nigricans is a condition characterized by the presence of symmetrical, brown, velvety plaques on the neck, axilla, and groin. This condition can be caused by various factors such as type 2 diabetes mellitus, gastrointestinal cancer, obesity, polycystic ovarian syndrome, acromegaly, Cushing’s disease, hypothyroidism, familial factors, Prader-Willi syndrome, and certain drugs like the combined oral contraceptive pill and nicotinic acid. The pathophysiology of acanthosis nigricans involves insulin resistance, which leads to hyperinsulinemia. This, in turn, stimulates the proliferation of keratinocytes and dermal fibroblasts through interaction with insulin-like growth factor receptor-1 (IGFR1).

Treatment Options for Migraines: A Comparison of Medications

Migraines are a recurring type of headache that can last for several hours to a few days. They are often accompanied by symptoms such as sensitivity to light and sound, nausea, and vomiting. There are several medications available for the treatment of migraines, each with its own benefits and drawbacks.

Ibuprofen is a simple analgesic that is recommended by the National Institute for Health and Care Excellence (NICE) for the treatment of acute migraine attacks. It is safe for patients with ischaemic heart disease, but the daily dose should not exceed 1200 mg.

Sumatriptan is a serotonin-receptor agonist that causes intracerebral vasoconstriction. It is recommended by NICE for the treatment of acute migraines, but it is contraindicated in patients with a history of ischaemic heart disease.

Amitriptyline is a tricyclic antidepressant that is used for long-term prophylaxis of migraines. It is recommended by NICE for this use but not for acute treatment.

Co-codamol, an opiate medication, is not recommended by NICE for the treatment of migraines due to the risk of medication-overuse headache and worsening of nausea and vomiting symptoms.

Ergotamine tartrate, another medication that was previously used to treat migraines, is now limited in use due to its unpleasant side effects such as nausea and vomiting. NICE advises against its use for the treatment of acute migraines.

In conclusion, the choice of medication for the treatment of migraines should be based on the patient’s medical history and the severity of their symptoms. Patients should consult with their healthcare provider to determine the best treatment plan for their individual needs.

Diagnostic Tests for Haemophilia and Related Conditions

Haemophilia is a genetic disorder that affects the blood’s ability to clot properly, leading to spontaneous or excessive bleeding. To diagnose haemophilia and related conditions, several diagnostic tests are available.

Factor IX Activity Level: Lack of factor IX leads to Christmas disease, the second most common type of haemophilia. To diagnose haemophilia, the levels of clotting factor present in the blood must be measured.

Platelet Count: The platelet count is usually normal in patients with haemophilia. Reduced platelets would suggest an alternative diagnosis. However, it is still important to check the platelet count to exclude thrombocytopenia as a cause of unexplained bleeding.

Activated Partial Thromboplastin Time (aPTT): Blood tests in haemophilia usually demonstrate a prolonged aPTT. However, patients with moderate disease can still have a normal aPTT if their factor activity level is > 15%.

Urinalysis: Urinalysis in patients with haemophilia may demonstrate the presence of haematuria, but by itself is not diagnostic of the condition.

von Willebrand Factor Antigen: The plasma von Willebrand factor antigen is normal in individuals with haemophilia. Reduced von Willebrand factor suggests the possibility of von Willebrand disease (VWD).

In conclusion, a combination of these diagnostic tests is necessary to diagnose haemophilia and related conditions accurately.

The investigation of maternal deaths in the UK is carried out by the Confidential Enquiry into Maternal Deaths, which encompasses deaths occurring during pregnancy, labour, and up to six weeks after delivery. Post partum haemorrhage (PPH) is a leading cause of maternal mortality. A stillbirth is defined as the loss of a fetus after twenty weeks gestation, while any loss prior to this is classified as a miscarriage.

Perinatal Death Rates and Related Metrics

Perinatal mortality rate is a measure of stillbirths and early neonatal deaths within seven days per 1,000 births after 24 weeks of gestation. In the UK, this rate is around 6 per 1,000 births. This figure is usually broken down into 4 per 1,000 stillbirths and 2 per 1,000 early neonatal deaths.

Maternal mortality rate, on the other hand, is calculated by dividing the number of deaths during pregnancy, labor, and six weeks after delivery by the total number of maternities and multiplying the result by 1000. Meanwhile, the stillbirth rate is determined by dividing the number of babies born dead after 24 weeks by the total number of births (live and stillborn) and multiplying the result by 1000. Lastly, the neonatal death rate is computed by dividing the number of babies who died between 0-28 days by the total number of live births and multiplying the result by 1000.

These metrics are important in assessing the quality of perinatal care and identifying areas for improvement. By monitoring these rates, healthcare providers can work towards reducing perinatal deaths and improving maternal and neonatal outcomes.

The patient has suffered a third degree perineal tear that has extended beyond the perineal mucosa and muscle, involving the EAS but not the rectal mucosa. Therefore, it is classified as a third degree tear. The appropriate course of action is to repair the tear in theatre by a clinician who is suitably trained. Repairing the tear on the ward by a midwife is not an option as it is a third degree tear. Similarly, repairing it in theatre by a clinician trained for fourth degree tears is not necessary. It is important to note that first degree tears do not require repair, but in this case, as it is a third degree tear, not repairing it would not be appropriate as it may not heal properly.

Perineal tears are a common occurrence during childbirth, and the Royal College of Obstetricians and Gynaecologists (RCOG) has developed guidelines to classify them based on their severity. First-degree tears are superficial and do not require any repair, while second-degree tears involve the perineal muscle and require suturing by a midwife or clinician. Third-degree tears involve the anal sphincter complex and require repair in theatre by a trained clinician, with subcategories based on the extent of the tear. Fourth-degree tears involve the anal sphincter complex and rectal mucosa and also require repair in theatre by a trained clinician.

There are several risk factors for perineal tears, including being a first-time mother, having a large baby, experiencing a precipitant labour, and having a shoulder dystocia or forceps delivery. It is important for healthcare providers to be aware of these risk factors and to provide appropriate care and management during childbirth to minimize the risk of perineal tears. By following the RCOG guidelines and providing timely and effective treatment, healthcare providers can help ensure the best possible outcomes for both mother and baby.

Venous Thromboembolism: Common Risk Factors

Venous thromboembolism (VTE) is a condition where blood clots form in the veins, which can lead to serious complications such as pulmonary embolism (PE). While there are many factors that can increase the risk of VTE, some are more common than others. These include malignancy, pregnancy, and the period following an operation. Other general risk factors include advancing age, obesity, family history of VTE, immobility, hospitalization, anaesthesia, and the use of central venous catheters. Underlying conditions such as heart failure, thrombophilia, and antiphospholipid syndrome can also increase the risk of VTE. Additionally, certain medications like the combined oral contraceptive pill, hormone replacement therapy, raloxifene, tamoxifen, and antipsychotics have been shown to be risk factors.

It is important to note that while these factors can increase the risk of VTE, around 40% of patients diagnosed with a PE have no major risk factors.

Understanding Necrotising Enterocolitis

Necrotising enterocolitis is a serious condition that is responsible for a significant number of premature infant deaths. The condition is characterized by symptoms such as feeding intolerance, abdominal distension, and bloody stools. If left untreated, these symptoms can quickly progress to more severe symptoms such as abdominal discolouration, perforation, and peritonitis.

To diagnose necrotising enterocolitis, doctors often use abdominal x-rays. These x-rays can reveal a number of important indicators of the condition, including dilated bowel loops, bowel wall oedema, and intramural gas. Other signs that may be visible on an x-ray include portal venous gas, pneumoperitoneum resulting from perforation, and air both inside and outside of the bowel wall. In some cases, an x-ray may also reveal air outlining the falciform ligament, which is known as the football sign.

Overall, understanding the symptoms and diagnostic indicators of necrotising enterocolitis is crucial for early detection and treatment of this serious condition. By working closely with healthcare professionals and following recommended screening protocols, parents and caregivers can help ensure the best possible outcomes for premature infants at risk for this condition.

It is probable that this individual is suffering from ulcerative colitis, a condition that is commonly linked to arthritis in large joints, sacroiliitis, and pyoderma gangrenosum.

Understanding Pyoderma Gangrenosum

Pyoderma gangrenosum is a rare inflammatory disorder that causes painful skin ulceration. While it can affect any part of the skin, it is most commonly found on the lower legs. This condition is classified as a neutrophilic dermatosis, which means that it is characterized by the infiltration of neutrophils in the affected tissue. The exact cause of pyoderma gangrenosum is unknown in 50% of cases, but it can be associated with inflammatory bowel disease, rheumatological conditions, haematological disorders, and other diseases.

The initial symptoms of pyoderma gangrenosum may start suddenly with a small pustule, red bump, or blood-blister. The skin then breaks down, resulting in an ulcer that is often painful. The edge of the ulcer is typically described as purple, violaceous, and undermined. In some cases, systemic symptoms such as fever and myalgia may also be present. Diagnosis is often made by the characteristic appearance, associations with other diseases, the presence of pathergy, histology results, and ruling out other potential causes.

Management of pyoderma gangrenosum typically involves oral steroids as first-line treatment due to the potential for rapid progression. Other immunosuppressive therapies such as ciclosporin and infliximab may also be used in difficult cases. It is important to note that any surgery should be postponed until the disease process is controlled on immunosuppression to avoid worsening the condition. Understanding pyoderma gangrenosum and seeking prompt medical attention can help manage this rare and painful condition.

Cyclizine is a recommended first choice anti-emetic for nausea and vomiting caused by intracranial or intra-vestibular issues. It is also useful in palliative care for managing gastrointestinal obstruction and vagally-mediated nausea or vomiting caused by mechanical bowel obstruction, movement disorders, or raised intracranial pressure. Domperidone is effective for gastro-intestinal pain in palliative care, while metoclopramide is used for acute migraine, chemotherapy or radiotherapy-induced nausea and vomiting. Ondansetron is indicated for chemotherapy-related nausea and vomiting. Dexamethasone is a steroid that may be used in palliative care for treating nausea, anorexia, spinal cord compression, and liver capsule pain. If the cause of nausea is suspected to be raised intracranial pressure, cyclizine should be the first-line option, and dexamethasone may be considered as an additional treatment.

Managing Nausea and Vomiting in Palliative Care: A Mechanistic Approach

Nausea and vomiting are common symptoms in palliative care, often caused by multiple factors. Identifying the primary cause is crucial in selecting the appropriate anti-emetic therapy. Six broad syndromes have been identified, with gastric stasis and chemical disturbance being the most common. In palliative care, pharmacological therapy is the first-line method for treating nausea and vomiting. Two approaches can be used in selecting drug therapy: empirical or mechanistic. The mechanistic approach matches the choice of anti-emetic drug to the likely cause of the patient’s symptoms.

The mechanistic approach involves selecting medication based on the underlying cause of the nausea and vomiting. For example, pro-kinetic agents are useful in scenarios where reduced gastric motility is the primary cause. First-line medications for this syndrome include metoclopramide and domperidone. However, metoclopramide should not be used in certain situations, such as complete bowel obstruction or gastrointestinal perforation. If the cause is chemically mediated, correcting the chemical disturbance should be the first step. Key treatment options include ondansetron, haloperidol, and levomepromazine. Cyclizine and levomepromazine are first-line for visceral/serosal causes, while cyclizine is recommended for nausea and vomiting due to intracranial disease. If the oral route is not possible, the parenteral route of administration is preferred, with the intravenous route used if access is already established.

In summary, a mechanistic approach to managing nausea and vomiting in palliative care involves selecting medication based on the underlying cause of the symptoms. This approach can improve the effectiveness of anti-emetic therapy and reduce the risk of adverse effects.

Antiretroviral therapy (ART) for HIV involves a combination of at least three drugs, typically two nucleoside reverse transcriptase inhibitors (NRTI) and either a protease inhibitor (PI) or a non-nucleoside reverse transcriptase inhibitor (NNRTI). Entry inhibitors, NRTIs, NNRTIs, PIs, and integrase inhibitors are all used to manage HIV. The 2015 BHIVA guidelines recommend starting ART as soon as a patient is diagnosed with HIV. Each drug has its own side effects, and some of the common ones include peripheral neuropathy, renal impairment, osteoporosis, diabetes, hyperlipidemia, and P450 enzyme interaction.

The definitive treatment for acute angle-closure glaucoma is laser peripheral iridotomy, which creates an additional pathway in the iris for aqueous to flow from the posterior chamber to the anterior chamber and be drained into the angle. While topical beta blockers, alpha agonists, prostaglandin analogues, and carbonic anhydrase inhibitors can all help control intraocular pressure in glaucoma patients, they are not considered definitive treatments for AACG.

Glaucoma is a group of disorders that cause optic neuropathy due to increased intraocular pressure (IOP). However, not all patients with raised IOP have glaucoma, and vice versa. Acute angle-closure glaucoma (AACG) is a type of glaucoma where there is a rise in IOP due to impaired aqueous outflow. Factors that increase the risk of AACG include hypermetropia, pupillary dilatation, and lens growth associated with age. Symptoms of AACG include severe pain, decreased visual acuity, haloes around lights, and a hard, red-eye. Management of AACG is an emergency and requires urgent referral to an ophthalmologist. Emergency medical treatment is necessary to lower the IOP, followed by definitive surgical treatment once the acute attack has subsided.

There are no specific guidelines for the initial medical treatment of AACG, but a combination of eye drops may be used, including a direct parasympathomimetic, a beta-blocker, and an alpha-2 agonist. Intravenous acetazolamide may also be administered to reduce aqueous secretions. Definitive management of AACG involves laser peripheral iridotomy, which creates a small hole in the peripheral iris to allow aqueous humour to flow to the angle. It is important to seek medical attention immediately if symptoms of AACG are present to prevent permanent vision loss.

Muscle Effects of Common Medications

Many medications can have effects on muscles, including statins, metoclopramide, amitriptyline, cyclizine, and venlafaxine. Statins can increase the risk of muscle toxicity, especially in patients with a history of muscular disorders, high alcohol intake, renal impairment, or hypothyroidism. Metoclopramide is associated with extrapyramidal symptoms and acute dystonic reactions, but not generalised myositis. Amitriptyline and cyclizine are rarely associated with extrapyramidal symptoms and tremor, and amitriptyline may cause myalgia on drug withdrawal. Venlafaxine commonly causes hypertonia and tremor, and more rarely myoclonus, but not generalised myositis. It is important to be aware of these potential muscle effects when prescribing and monitoring these medications.

Muscle Effects of Commonly Prescribed Medications

Lichen planus is a rash that appears as purple, itchy, polygonal papules on the flexor surfaces of the body. It is often accompanied by Wickham’s striae on the surface and can also affect the mouth. In contrast, lichen sclerosus is characterized by white, itchy spots that commonly appear on the vulva of older women.

Understanding Lichen Planus

Lichen planus is a skin condition that is believed to be caused by an immune response, although the exact cause is unknown. It is characterized by an itchy, papular rash that typically appears on the palms, soles, genitalia, and flexor surfaces of the arms. The rash often has a polygonal shape and a distinctive white-lines pattern on the surface, known as Wickham’s striae. In some cases, new skin lesions may appear at the site of trauma, a phenomenon known as the Koebner phenomenon.

Oral involvement is common in around 50% of patients, with a white-lace pattern often appearing on the buccal mucosa. Nail changes may also occur, including thinning of the nail plate and longitudinal ridging. Lichenoid drug eruptions can be caused by certain medications, such as gold, quinine, and thiazides.

The main treatment for lichen planus is potent topical steroids. For oral lichen planus, benzydamine mouthwash or spray is recommended. In more extensive cases, oral steroids or immunosuppression may be necessary.

Vitreous hemorrhage caused by proliferative retinopathy is more frequently observed in individuals with T1DM compared to T2DM. This is due to the presence of retinal neovascularization, which results in fragile blood vessels that are susceptible to bleeding. Conversely, vitreous hemorrhage is not typically associated with background, pre-proliferative diabetic retinopathy, or diabetic maculopathy as these conditions do not involve retinal neovascularization.

Understanding Diabetic Retinopathy

Diabetic retinopathy is a leading cause of blindness among adults aged 35-65 years old. The condition is caused by hyperglycemia, which leads to abnormal metabolism in the retinal vessel walls and damage to endothelial cells and pericytes. This damage causes increased vascular permeability, resulting in exudates seen on fundoscopy. Pericyte dysfunction predisposes to the formation of microaneurysms, while neovascularization is caused by the production of growth factors in response to retinal ischemia.

Patients with diabetic retinopathy are classified into those with non-proliferative diabetic retinopathy (NPDR), proliferative retinopathy (PDR), and maculopathy. NPDR is further classified into mild, moderate, and severe, depending on the presence of microaneurysms, blot hemorrhages, hard exudates, cotton wool spots, venous beading/looping, and intraretinal microvascular abnormalities. PDR is characterized by retinal neovascularization, which may lead to vitreous hemorrhage, and fibrous tissue forming anterior to the retinal disc. Maculopathy is based on location rather than severity and is more common in Type II DM.

Management of diabetic retinopathy involves optimizing glycaemic control, blood pressure, and hyperlipidemia, as well as regular review by ophthalmology. Treatment options include intravitreal vascular endothelial growth factor (VEGF) inhibitors for maculopathy, regular observation for non-proliferative retinopathy, and panretinal laser photocoagulation and intravitreal VEGF inhibitors for proliferative retinopathy. Vitreoretinal surgery may be necessary in cases of severe or vitreous hemorrhage.

For patients with refractory anaphylaxis, which is characterized by persistent respiratory and/or cardiovascular problems despite receiving 2 doses of intramuscular adrenaline, the recommended next step is to start an intravenous adrenaline infusion. Administering further intramuscular adrenaline is not recommended. Intravenous chlorphenamine and hydrocortisone are also no longer recommended in the updated guidelines for anaphylaxis management.

Anaphylaxis is a severe and potentially life-threatening allergic reaction that affects the entire body. It can be caused by various triggers, including food, drugs, and insect venom. The symptoms of anaphylaxis typically occur suddenly and progress rapidly, affecting the airway, breathing, and circulation. Common signs include swelling of the throat and tongue, hoarse voice, respiratory wheeze, dyspnea, hypotension, and tachycardia. In addition, around 80-90% of patients experience skin and mucosal changes, such as generalized pruritus, erythematous rash, or urticaria.

The management of anaphylaxis requires prompt and decisive action, as it is a medical emergency. The Resuscitation Council guidelines recommend intramuscular adrenaline as the most important drug for treating anaphylaxis. The recommended doses of adrenaline vary depending on the patient’s age, ranging from 100-150 micrograms for infants under 6 months to 500 micrograms for adults and children over 12 years. Adrenaline can be repeated every 5 minutes if necessary, and the best site for injection is the anterolateral aspect of the middle third of the thigh. In cases of refractory anaphylaxis, IV fluids and expert help should be sought.

Following stabilisation, patients may be given non-sedating oral antihistamines to manage persisting skin symptoms. It is important to refer all patients with a new diagnosis of anaphylaxis to a specialist allergy clinic and provide them with an adrenaline injector as an interim measure before the specialist assessment. Patients should also be prescribed two adrenaline auto-injectors and trained on how to use them. A risk-stratified approach to discharge should be taken, as biphasic reactions can occur in up to 20% of patients. The Resus Council UK recommends a fast-track discharge for patients who have had a good response to a single dose of adrenaline and complete resolution of symptoms, while those who require two doses of IM adrenaline or have a history of biphasic reaction should be observed for at least 12 hours following symptom resolution.

Anticoagulant Therapy for Deep Vein Thrombosis in Pregnancy

Deep vein thrombosis (DVT) is a serious condition that can occur during pregnancy. Any woman with symptoms or signs suggestive of DVT should undergo objective testing and receive treatment with low-molecular-weight heparin (LMWH) immediately until the diagnosis is excluded. LMWH should be given in doses titrated against the woman’s weight and can be administered once daily or in two divided doses. It does not cross the placenta and has a lower risk of bleeding and heparin-induced osteoporosis compared to unfractionated heparin (UH). Fondaparinux, argatroban, or r-hirudin may be considered for pregnant women who cannot tolerate heparin.

Aspirin is not recommended for thromboprophylaxis in obstetric patients, except for pregnant women with a known history of antiphospholipid syndrome. Intravenous UH is the preferred initial treatment for massive pulmonary embolism with cardiovascular compromise during pregnancy and the puerperium. Warfarin should not be used for antenatal DVT treatment due to its adverse effects on the fetus. Postnatal therapy can be with LMWH or oral anticoagulants, but regular blood tests are needed to monitor warfarin.

Compression duplex ultrasonography should be performed when there is clinical suspicion of DVT. D-dimer testing should not be used in the investigation of acute DVT in pregnancy. Before anticoagulant therapy is started, blood tests should be taken for a full blood count, coagulation screen, urea and electrolytes, and liver function tests. Thrombophilia screening before therapy is not recommended.

Statin therapy is not recommended during pregnancy

The correct statement is that all statins, including atorvastatin, are not recommended during pregnancy due to potential risks to the developing fetus. While there is no conclusive evidence of teratogenicity, there have been reports of adverse outcomes such as intrauterine growth restriction and fetal demise in women taking statins during the first trimester. Lipophilic statins like atorvastatin can cross the placenta and reach similar concentrations in both the mother and fetus.

Clozapine is not a contraindication during pregnancy, as it is an atypical antipsychotic used to treat schizophrenia that is unresponsive to other medications. While caution is advised when using clozapine during pregnancy, it is not considered a contraindication.

Lamotrigine is also not contraindicated during pregnancy, as it is generally considered safe for use in pregnant women. Unlike many other antiepileptic drugs, lamotrigine has not been associated with an increased risk of congenital malformations.

Low-molecular-weight-heparin is also not contraindicated during pregnancy, and is often prescribed for women with antiphospholipid syndrome to prevent blood clots. This medication does not cross the placenta and is considered safe for use during pregnancy.

Statins are drugs that inhibit the action of an enzyme called HMG-CoA reductase, which is responsible for producing cholesterol in the liver. However, they can cause some adverse effects such as myopathy, which includes muscle pain, weakness, and damage, and liver impairment. Myopathy is more common in lipophilic statins than in hydrophilic ones. Statins may also increase the risk of intracerebral hemorrhage in patients who have had a stroke before. Therefore, they should be avoided in these patients. Statins should not be taken during pregnancy and should be stopped if the patient is taking macrolides.

Statins are recommended for people with established cardiovascular disease, those with a 10-year cardiovascular risk of 10% or more, and patients with type 2 diabetes mellitus. Patients with type 1 diabetes mellitus who were diagnosed more than 10 years ago, are over 40 years old, or have established nephropathy should also take statins. It is recommended to take statins at night as this is when cholesterol synthesis takes place. Atorvastatin 20mg is recommended for primary prevention, and the dose should be increased if non-HDL has not reduced for 40% or more. Atorvastatin 80 mg is recommended for secondary prevention. The graphic shows the different types of statins available.

Differential Diagnosis for Confusion in a Patient with Alcohol Misuse

Wernicke Encephalopathy (WE), caused by thiamine deficiency and commonly associated with chronic alcoholism, is a serious neurological disorder that presents with a classic triad of ocular findings, cerebellar dysfunction, and confusion. Rapid correction of brain thiamine deficiency is crucial, and treatment is initially administered parenterally. Neurological dysfunction, especially memory and learning impairment, can persist even after treatment, leading to Korsakoff syndrome.

Subdural hematoma, more common in individuals who misuse alcohol, is an important differential diagnosis in cases of acute confusion. However, a history of head injury, even minor, and a headache with or without vomiting are typically present. Acute hematomas present soon after the injury, while chronic hematomas may not present until 2-3 weeks after the trauma.

Acute alcohol poisoning is unlikely in a patient with worsening confusion over the past week. Sudden onset of confusion following an alcohol binge that improves with abstinence is expected.

Hepatic encephalopathy, a spectrum that develops in patients with advanced liver disease, may present with a change in personality, short-term memory loss, or reduced level of consciousness. However, cerebellar signs such as nystagmus and ataxia are not associated with this condition.

Delirium tremens, a rapid onset of confusion as a result of alcohol withdrawal, typically appears three days after abstinence from alcohol and may include visual hallucinations, acute confusion, and tremor. If untreated, seizures may occur. However, the presence of nystagmus and ataxia in this case makes WE the more likely diagnosis.

Fitz-Hugh-Curtis syndrome is a condition that arises as a result of pelvic inflammatory disease. It causes inflammation of the liver capsule, leading to pain in the upper right quadrant of the abdomen. Scar tissue formation and peri-hepatic adhesions may also occur. This condition is more common in women who have contracted chlamydia or gonorrhoea. Treatment involves eliminating the responsible organism, and in some cases, laparoscopy may be necessary to remove adhesions that have formed.

Chlamydia is a common sexually transmitted infection caused by Chlamydia trachomatis. It is prevalent in the UK, with approximately 1 in 10 young women affected. The incubation period is around 7-21 days, but many cases are asymptomatic. Symptoms in women include cervicitis, discharge, and bleeding, while men may experience urethral discharge and dysuria. Complications can include epididymitis, pelvic inflammatory disease, and infertility.

Traditional cell culture is no longer widely used for diagnosis, with nuclear acid amplification tests (NAATs) being the preferred method. Testing can be done using urine, vulvovaginal swab, or cervical swab. Screening is recommended for sexually active individuals aged 15-24 years, and opportunistic testing is common.

Doxycycline is the first-line treatment for Chlamydia, with azithromycin as an alternative if doxycycline is contraindicated or not tolerated. Pregnant women may be treated with azithromycin, erythromycin, or amoxicillin. Patients diagnosed with Chlamydia should be offered partner notification services, with all contacts since the onset of symptoms or within the last six months being notified and offered treatment.